FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

13029711000001107: Co-cyprindiol 2000microgram/35microgram tablets 21 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
45928501000001113 Co-cyprindiol 2000microgram/35microgram tablets 21 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
45928601000001112 Co-cyprindiol 2000microgram/35microgram tablets 21 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-cyprindiol 2000microgram/35microgram tablets 21 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets 21 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets 21 tablet Is pack of Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets 21 tablet Has active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets 21 tablet Has active ingredient Cyproterone acetate false Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets 21 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets 21 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets 21 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets 21 tablet Has VMP Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets 21 tablet Has specific active ingredient Cyproterone acetate true Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets 21 tablet Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets 21 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Clairette 2000/35 tablets (Kent Pharma (UK) Ltd) 21 tablet Is a True Co-cyprindiol 2000microgram/35microgram tablets 21 tablet Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (PLIVA Pharma Ltd) 21 tablet 3 x 7 tablets Is a True Co-cyprindiol 2000microgram/35microgram tablets 21 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start